统计日期股东户数户均持股数（万股）户均持股市值（万元） 2025/06/30820430.547.662025/03/31681550.656.082024/09/30451640.987.392024/06/30481530.926.282024/03/31535830.847.38 来源：金融界 截至发稿，创新医疗报18.61元，上涨5.74%，市值82.12亿元。 最新5个统计日期，创新医疗股东户数变动如下： 从8月9日公开信息显示，创新医疗截至2025年6月30日公司股东户数为8.20万户，较上期（2025年3月31日）增加1.39万 户，增幅为20.38%，持股趋于分散。 从数据对比来看，创新医疗户均持股数从上期0.65万股下降至本期0.54万股，户均持股市值从上期6.08万元上升至本期 7.66万元。上述区间，创新医疗股价累计上涨101.83%。 ...

从8月6日公开信息显示，科锐国际截至2025年7月31日公司股东户数为1.04万户，较上期（2025年7月18日）减少3741户，降 幅为26.37%，持股趋于集中。 来源：金融界 从数据对比来看，科锐国际户均持股数从上期1.39万股上升值本期1.88万股,户均持股市值从上期43.86万元上升至本期67.45万 元。上述区间，科锐国际股价累计上涨2.74%。 统计日期股东户数户均持股数（万股）户均持股市值（万元） 2025/07/31104481.8867.452025/07/18141891.3943.862025/07/10103571.9056.402025/06/20107931.8247.302025/06/10119291.6544.89 截至发稿，科锐国际报32.65元，下跌1.03%，市值64.26亿元。 最新5个统计日期，科锐国际股东户数变动如下： ...

Summary of Key Points Core Viewpoint The recent data indicates a significant decline in the number of shareholders for many companies, with a notable concentration of stocks showing varying performance in the market. This trend highlights potential investment opportunities and risks associated with shareholder dynamics and stock performance. Group 1: Shareholder Dynamics - A total of 731 companies reported their shareholder numbers as of July 31, with 386 showing a decline compared to the previous period [1][3] - Among the companies with a decline in shareholder numbers, 46 experienced a drop of over 10% [3] - The largest decline was observed in Lianfa Co., with a 42.44% decrease in shareholder numbers, totaling 31,362 [3][4] Group 2: Stock Performance - The average increase for concentrated stocks from July 11 to July 20 was 4.36%, outperforming the Shanghai Composite Index, which rose by 3.07% [2] - Among the stocks with a decline in shareholder numbers, Kanghong Pharmaceutical had the highest increase of 44.59% during the same period [2] - The latest concentrated stocks showed an average increase of 2.79% since July 21, with notable performers including Lideman, Beifang Changlong, and Guoji Jinggong, which rose by 65.29%, 57.37%, and 38.05% respectively [3][4] Group 3: Earnings Reports - Six concentrated stocks have released their semi-annual reports, with Daodaquan showing the highest net profit growth of 563.15% year-on-year [4] - Five companies reported significant profit increases, including Beiding Co. and Guoyuan Securities, with growth rates of 74.92% and 40.44% respectively [4] - A total of 118 companies issued profit forecasts, with 36 expecting an increase and 17 anticipating profitability [4]

Core Viewpoint - Zhuhai Port's stock price remained stable at 5.46 yuan as of August 4, 2025, with a slight fluctuation during the trading day [1] Company Overview - Zhuhai Port operates in key sectors including port shipping, logistics, and energy, making it a significant port operator in South China [1] - The company's segments include shipping ports, Guangdong region, and natural gas [1] Shareholder Information - As of July 31, 2025, the number of shareholders decreased to 76,900, a decline of 1,086 shareholders or 1.39% [1] - The average number of shares held per shareholder slightly increased, with an average market value of 63,600 yuan, which is below the average level of the public utility industry [1] - The number of shares held through the Shenzhen Stock Connect remained at 4.0204 million shares, accounting for 0.43% of the circulating share capital [1] Capital Flow - On August 4, 2025, there was a net outflow of main funds amounting to 8.9119 million yuan, with a cumulative net outflow of 28.9296 million yuan over the past five days [1]

Group 1 - The core point of the article indicates that Wuzhou Medical has seen an increase in the number of shareholders, with a total of 7,255 shareholders as of July 31, 2025, representing a growth of 848 shareholders or 13.24% compared to the previous period [1] - The average number of shares held per shareholder decreased from 10,600 shares to 9,400 shares, while the average market value of shares held increased from 317,400 yuan to 377,000 yuan [1] - During the same period, Wuzhou Medical's stock price rose by 13.27% [1] Group 2 - As of the latest report, Wuzhou Medical's stock price is 42.18 yuan, reflecting an increase of 3.64%, with a market capitalization of 2.868 billion yuan [1] - The changes in the number of shareholders and their holdings over the last five reporting dates are detailed, showing a trend of increasing shareholder numbers and fluctuating average holdings [1]

Group 1 - The core point of the article highlights that the number of shareholders for the company has decreased for the fourth consecutive period, with a total of 18,158 shareholders as of July 31, representing a decline of 1,331 shareholders or 6.83% compared to the previous period [2] - The company's stock price closed at 32.54 yuan, down 8.34%, with a cumulative decline of 3.61% since the concentration of shares began [2] - The company's Q1 report indicates that it achieved a revenue of 793 million yuan, a year-on-year increase of 15.27%, and a net profit of 156 million yuan, a year-on-year increase of 28.73%, with basic earnings per share of 0.3900 yuan and a weighted average return on equity of 5.50% [2]

Group 1 - The company reported a decrease in the number of shareholders, with a total of 29,178 shareholders as of July 31, which is a reduction of 1,911 shareholders compared to the previous period (July 20), representing a decline of 6.15% [2] - This marks the second consecutive period of decline in the number of shareholders for the company [2] Group 2 - On July 15, the company released a performance forecast for the first half of the year, expecting a net profit loss between 930 million yuan and 530 million yuan [2]

Group 1 - The number of shareholders for the company as of July 31 is 443,058, a decrease of 42,209 from the previous period, representing a decline of 8.70% [2] - The latest stock price of the company is 22.64 yuan, down 0.79%, with a cumulative decline of 7.70% since the concentration of shares began, showing 3 days of increase and 8 days of decrease [2] - The company's Q1 report indicates a total revenue of 1.246 billion yuan, a year-on-year increase of 38.37%, and a net profit of -99.76 million yuan, a year-on-year increase of 27.67%, with basic earnings per share at -0.0600 yuan [2] Group 2 - On July 15, the company released a half-year performance forecast, expecting a net profit ranging from -100 million yuan to -90 million yuan [3]

Core Viewpoint - Jinling Mining reported a decrease in the number of shareholders, indicating a potential shift in investor sentiment and market dynamics [2]. Financial Performance - For Q1, the company achieved a revenue of 356 million yuan, representing a year-on-year growth of 26.98% [2]. - The net profit for Q1 was approximately 49.1 million yuan, showing a significant year-on-year increase of 122.53% [2]. - The basic earnings per share were reported at 0.0825 yuan, with a weighted average return on equity of 1.45% [2]. Shareholder Dynamics - As of July 31, the number of shareholders was 40,968, a decrease of 7,776 from the previous period, reflecting a decline of 15.95% [2]. - This marks the second consecutive period of decline in the number of shareholders [2]. Stock Performance - The closing price of Jinling Mining was 8.16 yuan, with a slight increase of 0.49% [2]. - Since the concentration of shares began, the stock price has seen a cumulative decline of 1.03%, with 4 days of increase and 5 days of decrease in the trading period [2]. Earnings Forecast - The company projected a net profit for the first half of the year between 133 million and 169 million yuan, with a fluctuation range of 66.48% to 111.54% [2].

Core Viewpoint - The company, Huizhong Co., has experienced a decline in the number of shareholders for the second consecutive period, indicating potential concerns regarding investor confidence and stock performance [2]. Group 1: Shareholder Information - As of July 31, the number of shareholders for Huizhong Co. was 12,978, a decrease of 1,460 from the previous period (July 20), representing a decline of 10.11% [2]. - This marks the second consecutive decline in the number of shareholders for the company [2]. Group 2: Stock Performance - The closing price of Huizhong Co. was 12.80 yuan, reflecting an increase of 1.67%. Since the concentration of shares began, the stock price has cumulatively risen by 0.87% [2]. - The stock experienced five days of increases and five days of decreases during the reporting period [2]. Group 3: Financial Performance - In the first quarter, Huizhong Co. achieved operating revenue of 73.6493 million yuan, a year-on-year increase of 47.52%, and a net profit of 6.9693 million yuan, up 71.77% year-on-year [2]. - The basic earnings per share were 0.0350 yuan, with a weighted average return on equity of 0.62% [2]. - The company released a half-year performance forecast on July 9, estimating a net profit between 39.9762 million yuan and 42.0262 million yuan, with a variation range of 95.00% to 105.00% [2].